Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginie Vlaeminck-Guillem

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|June 29, 2018
Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and ManagementVirginie Vlaeminck-Guillem
Diagnostics (Basel, Switzerland)|February 9, 2016
When Prostate Cancer Circulates in the BloodstreamVirginie Vlaeminck-Guillem
Frontiers in Oncology|September 4, 2014
SRC: marker or actor in prostate cancer aggressivenessVirginie Vlaeminck-Guillem, Germain Gillet, Ruth Rimokh
Medecine Sciences : M/S|December 4, 2003
[Negative cross-talk between nuclear receptors and transcription factors: implications in inflammation and oncogenesis]Virginie Vlaeminck-Guillem, Vincent Laudet, Martine Duterque-Coquillaud
Presse Medicale (Paris, France : 1983)|November 21, 2015
TRα receptor mutations extend the spectrum of syndromes of reduced sensitivity to thyroid hormoneVirginie Vlaeminck-Guillem, Stéphanie Espiard, Frédéric Flamant, et al.
Urology|July 10, 2009
Urinary prostate cancer 3 test: toward the age of reason?Virginie Vlaeminck-Guillem, Alain Ruffion, Jean André, et al.
Molecular Endocrinology (Baltimore, Md.)|March 30, 2002
Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonistVirginie Vlaeminck-Guillem, Su-Chin Ho, Patrice Rodien, et al.
Molecular and Cellular Endocrinology|September 14, 2021
Non-genomic signaling of steroid receptors in cancerCharlène Thiebaut, Virginie Vlaeminck-Guillem, Olivier Trédan, et al.
European Journal of Endocrinology|March 12, 2014
Endocrine side-effects of anti-cancer drugs: the impact of retinoids on the thyroid axisJulia Graeppi-Dulac, Virginie Vlaeminck-Guillem, Marie Perier-Muzet, et al.
The International Journal of Developmental Biology|June 3, 2006
Thyroid hormone receptor expression in the obligatory paedomorphic salamander Necturus maculosusVirginie Vlaeminck-Guillem, Rachid Safi, Philippe Guillem, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|June 29, 2018
Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and ManagementVirginie Vlaeminck-Guillem
Diagnostics (Basel, Switzerland)|February 9, 2016
When Prostate Cancer Circulates in the BloodstreamVirginie Vlaeminck-Guillem
Frontiers in Oncology|September 4, 2014
SRC: marker or actor in prostate cancer aggressivenessVirginie Vlaeminck-Guillem, Germain Gillet, Ruth Rimokh
Medecine Sciences : M/S|December 4, 2003
[Negative cross-talk between nuclear receptors and transcription factors: implications in inflammation and oncogenesis]Virginie Vlaeminck-Guillem, Vincent Laudet, Martine Duterque-Coquillaud
Presse Medicale (Paris, France : 1983)|November 21, 2015
TRα receptor mutations extend the spectrum of syndromes of reduced sensitivity to thyroid hormoneVirginie Vlaeminck-Guillem, Stéphanie Espiard, Frédéric Flamant, et al.
Urology|July 10, 2009
Urinary prostate cancer 3 test: toward the age of reason?Virginie Vlaeminck-Guillem, Alain Ruffion, Jean André, et al.
Molecular Endocrinology (Baltimore, Md.)|March 30, 2002
Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonistVirginie Vlaeminck-Guillem, Su-Chin Ho, Patrice Rodien, et al.
Molecular and Cellular Endocrinology|September 14, 2021
Non-genomic signaling of steroid receptors in cancerCharlène Thiebaut, Virginie Vlaeminck-Guillem, Olivier Trédan, et al.
European Journal of Endocrinology|March 12, 2014
Endocrine side-effects of anti-cancer drugs: the impact of retinoids on the thyroid axisJulia Graeppi-Dulac, Virginie Vlaeminck-Guillem, Marie Perier-Muzet, et al.
The International Journal of Developmental Biology|June 3, 2006
Thyroid hormone receptor expression in the obligatory paedomorphic salamander Necturus maculosusVirginie Vlaeminck-Guillem, Rachid Safi, Philippe Guillem, et al.
Pageof 4